SFX by Ex Libris Inc.

Title:	PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus
Source:	Nature Medicine [1078-8956] Barber, Domingo yr:2005

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Fuhler GM, Gwenny M. "Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer." Molecular medicine 18.1 (2012): 65-75.
description	2.	Kitagawa, S. "Functional micropore chemistry of crystalline metal complex-assembled compounds." Bulletin of the Chemical Society of Japan 71.8 (1998): 1739-1753.
description	3.	Rommel, C.. "PI3Kδ and PI3Kγ: Partners in crime in inflammation in rheumatoid arthritis and beyond?" Nature reviews. Immunology 7.3 (2007): 191-201.
description	4.	Comb WC. "p85alpha SH2 domain phosphorylation by IKK promotes feedback inhibition of PI3K and Akt in response to cellular starvation." Molecular cell 45.6 (2012): 719-.
description	5.	Batten, S. "Coordination polymers, metal-organic frameworks and the need for terminology guidelines." CrystEngComm 14.9 (2012): 3001-3004.
description	6.	Kerr, William G. "Inhibitor and activator: dual functions for SHIP in immunity and cancer." Annals of the New York Academy of Sciences 1217.1 (2010): 1-17.
description	7.	Wagner, U. "[How do T-cells become activated in joints?]." Zeitschrift für Rheumatologie 69.8 (2010): 738-742.
description	8.	Kaim, W. "Coordination compounds of pteridine, alloxazine and flavin ligands: structures and properties." Coordination chemistry reviews 182.1-2 (1999): 323-342.
description	9.	Immunology, N. "Nipping cat allergy with fusion proteins." Nature medicine 11.4 (2005): 381-2.
description	10.	Hennessy, Bryan T T. "Exploiting the PI3K/AKT pathway for cancer drug discovery." Nature reviews. Drug discovery 4.12: 988-1004.
description	11.	Schneiter, R. "Lipid signalling in disease." Nature reviews. Molecular cell biology 9.2 (2008): 162-76.
description	12.	Jung, J. "Particle design using supercritical fluids: Literature and patent survey." The Journal of supercritical fluids 20.3 (2001): 179-219.
description	13.	Choy, E H H. "Cytokine pathways and joint inflammation in rheumatoid arthritis." The New England journal of medicine 344.12 (2001): 907-16.
description	14.	Yaghi, Omar M. "Synthetic strategies, structure patterns, and emerging properties in the chemistry of modular porous solids." Accounts of chemical research 31.8 (1998): 474-484.
description	15.	Zhang, Jie-Peng P. "A flexible porous coordination polymer functionalized by unsaturated metal clusters." Angewandte Chemie (International ed.) 46.6 (2007): 889-892.
description	16.	Eddaoudi, M. "Modular chemistry: Secondary building units as a basis for the design of highly porous and robust metal-organic carboxylate frameworks." Accounts of chemical research 34.4 (2001): 319-330.
description	17.	Champness, Neil R. "The future of metal-organic frameworks." Dalton transactions 40.40 (2011): 10311-5.
description	18.	Fages, J. "Particle generation for pharmaceutical applications using supercritical fluid technology." Powder technology 141.3 (2004): 219-226.
description	19.	Lee, D M M. "Rheumatoid arthritis." The lancet 358.9285 (2001): 903-11.
description	20.	Hannun, Yusuf A. "Principles of bioactive lipid signalling: lessons from sphingolipids." Nature reviews. Molecular cell biology 9.2 (2008): 139-50.